Regulation and Role of aE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease

[1]  J. Elstrott,et al.  Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease , 2021, Cell reports. Medicine.

[2]  I. Ordás,et al.  Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative Colitis , 2020, Journal of Crohn's & colitis.

[3]  Aviv Regev,et al.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.

[4]  E. Butcher,et al.  Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. , 2018, Journal of Crohn's & colitis.

[5]  P. Rosenstiel,et al.  Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease , 2018, Gut.

[6]  P. Rutgeerts,et al.  Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC , 2016, Gut.

[7]  M. Neurath,et al.  Blockade of αEβ7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo , 2016, Gut.

[8]  Stefan Schreiber,et al.  Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis. , 2016, Gastroenterology.

[9]  E. Butcher,et al.  Leukocyte Trafficking to the Small Intestine and Colon. , 2016, Gastroenterology.

[10]  J. Mansfield,et al.  Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial , 2014, The Lancet.

[11]  Holger Fröhlich,et al.  TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level , 2014, BMC Systems Biology.

[12]  D. Bluteau,et al.  Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes , 2014, The Journal of Immunology.

[13]  J. Egen,et al.  Functional Consequences of the Macrophage Stimulating Protein 689C Inflammatory Bowel Disease Risk Allele , 2013, PloS one.

[14]  J. Fletcher,et al.  EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging , 2013, The American Journal of Gastroenterology.

[15]  Kristin Stephens,et al.  Vedolizumab as induction and maintenance therapy for Crohn's disease. , 2013, The New England journal of medicine.

[16]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[17]  J. Mansfield,et al.  A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis , 2012, Gut.

[18]  P. Rutgeerts,et al.  Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment , 2011, The American Journal of Gastroenterology.

[19]  R. Gentleman,et al.  Independent filtering increases detection power for high-throughput experiments , 2010, Proceedings of the National Academy of Sciences.

[20]  J. Grutters,et al.  Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography. , 2009, Clinical immunology.

[21]  M. Pekalski,et al.  Renal allograft rejection: the contribution of chemokines to the adhesion and retention of alphaE(CD103)beta7 integrin-expressing intratubular T cells. , 2008, Molecular immunology.

[22]  Gordon K. Smyth,et al.  A comparison of background correction methods for two-colour microarrays , 2007, Bioinform..

[23]  J. Varga,et al.  The Early-Immediate Gene EGR-1 Is Induced by Transforming Growth Factor-β and Mediates Stimulation of Collagen Gene Expression* , 2006, Journal of Biological Chemistry.

[24]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[25]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[26]  Subrata Ghosh,et al.  Natalizumab for active Crohn's disease. , 2003, The New England journal of medicine.

[27]  C. Elia,et al.  Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease , 1999, Gut.

[28]  E. Leung,et al.  The β7 integrin gene (Itgb-7) promoter is responsive to TGF-β1: defining control regions , 1998, Immunogenetics.

[29]  C. Mackay,et al.  Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. , 1997, The American journal of pathology.

[30]  E. Berg,et al.  A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. , 1996, Journal of immunology.

[31]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[32]  S. Nakamura,et al.  In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[33]  C. Benjamin,et al.  Expression of vascular adhesion molecules in inflammatory bowel disease. , 1992, Gastroenterology.

[34]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[35]  A. Braun,et al.  A Yin and Yang in Epithelial Immunology: The Roles of the αE(CD103)β7 Integrin in T Cells. , 2018, The Journal of investigative dermatology.

[36]  J. Mansfield,et al.  αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis. , 2016, Journal of Crohn's & colitis.

[37]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[38]  T. Halstensen,et al.  Topographic Distribution of Homing Receptors on B and T Cells in Human Gut-Associated Lymphoid Tissue Relation of L-Selectin and Integrin cx437 to Naive and Memory Phenotypes , 2007 .

[39]  A. Fischer,et al.  Blockade of the integrin alphaLbeta2 but not of integrins alpha4 and/or beta7 significantly prolongs intestinal allograft survival in mice. , 2000, Gut.

[40]  C. Griscelli,et al.  A monoclonal antibody (HML‐1) defining a novel membrane molecule present on human intestinal lymphocytes , 1987, European journal of immunology.